References
- Adeyeye, C. M., & Price, J. C. (1994). Development and evaluation of sustained-release ibuprofen-wax microspheres. II. In vitro dissolution studies. Pharmaceutical Research, 11, 575–579., [PUBMED], [INFOTRIEVE], [CSA]
- Bansal, A. K., Khar, R. K., Dubey, R., & Sharma, A. K. (1994). Effect of group substitution on the physicochemical properties of ibuprofen prodrugs. Pharmazie, 49, 422–424., [PUBMED], [INFOTRIEVE], [CSA]
- Bodmeier, R., & Wang, J. (1993). Microencapsulation of drugs with aqueous colloidal polymer dispersions. Journal of Pharmaceutical Sciences, 82, 191–194., [PUBMED], [INFOTRIEVE], [CSA]
- Bodmeier, R., Wang, J., & Bhagwatwar, H. (1992). Process and formulation variables in the preparation of wax microparticles by a melt dispersion technique. I. Oil-in-water technique for water-insoluble drugs. Journal of Microencapsulation, 9, 89–98., [PUBMED], [INFOTRIEVE], [CSA]
- Canaparo, R., Muntoni, E., Zara, G. P., Della, P., Pepa, C., Berno, E., Costa, M., & Eandi, M. (2000). Determination of Ibuprofen in human plasma by high-performance liquid chromatography: validation and application in pharmacokinetic study. Biomedical Chromatography, 14, 219–226., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Charoenchaitrakool, M., Dehghani, F., & Foster, N. R. (2002). Utilization of supercritical carbon dioxide for complex formation of ibuprofen and methyl-beta-cyclodextrin. International Journal of Pharmaceutics, 239, 103–112., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Choi, H. G., Oh, Y. K., & Kim, C. K. (1998). In-situ gelling and mucoadhesive liquid suppository containing acetaminophen: enhanced bioavailability. International Journal of Pharmaceutics, 165, 23–32., [CSA], [CROSSREF]
- Choi, H. G., Lee, B. J., Yong, C. S., Rhee, J. D., Han, J. H., Lee, M. K., Park, K. M., & Kim, C. K. (2001). Terfenadine-β-cyclodextrin inclusion complex with the anti-histaminic activity enhancement. Drug Development and Industrial Pharmacy, 27, 857–862., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- de Villiers, M. M., Liebenberg, W., Malan, S. F., & Gerber, J. J. (1999). The dissolution and complexing properties of ibuprofen and ketoprofen when mixed with N-methylglucamine. Drug Development and Industrial Pharmacy, 25, 967–972., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Geisslinger, G., Dietzel, K., Bezler, H., Nuernberg, B., & Brune, K. (1989). Therapeutically relevant differences in the pharmacokinetical and pharmaceutical behavior of ibuprofen lysinate as compared to ibuprofen acid. International Journal of Clinical Pharmacology, Therapy and Toxicology, 27, 324–328., [CSA]
- Ghorab, M. K., & Adeyeye, M. C. (2001). Enhancement of ibuprofen dissolution via wet granulation with beta-cyclodextrin. Pharmaceutical Development and Technology, 6, 305–314., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ghosh, L. K., Ghosh, N. C., Chatterjee, M., & Gupta, B. K. (1998). Product development studies on the tablet formulation of ibuprofen to improve bioavailability. Drug Development and Industrial Pharmacy, 24, 473–477., [PUBMED], [INFOTRIEVE], [CSA]
- Gibaldi, M., & Perrier, D. (1982). Pharmacokinetics (2nd ed.). New York: Marcel Dekker, Inc..
- Gillespie, W. R., DiSanto, A. R., Monovich, R. E., & Albert, K. S. (1982). Relative bioavailability of commercially available ibuprofen oral dosage forms in humans. Journal of Pharmaceutical Sciences, 71, 1034–1038., [PUBMED], [INFOTRIEVE], [CSA]
- Glowka, F. K. (2000). Stereoselective pharmacokinetics of ibuprofen and its lysinate from suppositories in rabbits. International Journal of Pharmaceutics, 199, 159–166., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Greenhalgh, D. J., Williams, A. C., Timmins, P., & York, P. (1999). Solubility parameters as predictors of miscibility in solid dispersions. Journal of Pharmaceutical Sciences, 88, 1182–1190., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Haikala, V. E., Heimonen, I. K., & Vuorela, H. J. (1991). Determination of ibuprofen in ointments by reversed-phase liquid chromatography. Journal of Pharmaceutical Sciences, 80, 456–458., [PUBMED], [INFOTRIEVE], [CSA]
- Hussain, M. D., Rogers, J. A., Mehvar, R., & Vudathala, G. K. (1999). Preparation and release of ibuprofen from polyacrylamide gels. Drug Development and Industrial Pharmacy, 25, 265–271., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kachrimanis, K., Nikolakakis, I., & Malamataris, S. (2000). Spherical crystal agglomeration of ibuprofen by the solvent-change technique in presence of methacrylic polymers. Journal of Pharmaceutical Sciences, 89, 250–259., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kaka, J. S., & Tekle, A. (1992). Bioavailability of ibuprofen from oral and suppository preparations in rats. Research Communications in Chemical Pathology and Pharmacology, 76, 171–182., [PUBMED], [INFOTRIEVE], [CSA]
- Khan, G. M., & Jiabi, Z. (1998). Preparation. characterization, and dissolution studies of ibuprofen solid dispersions using polyethylene glycol (PEG), talc, and PEG-talc as dispersion carriers. Drug Development and Industrial Pharmacy, 24, 455–462., [PUBMED], [INFOTRIEVE], [CSA]
- Kokot, Z., & Zmidzinska, H. (2001). Solubility and dissolution rate of ibuprofen in ionic and non-ionic micellar systems. Acta Poloniae Pharmaceutica, 58, 117–120., [PUBMED], [INFOTRIEVE], [CSA]
- Li, C. J., Higashiyama, K., Yoshimura, Y., Nagai, T., Takayama, T. K., & Obata, Y. (2001). Promoting mechanism of menthol derivative. 1-O-ethyl-3-buthylcyclohexanol, on the percutaneous absorption of ketoprofen. Biological & Pharmaceutical Bulletin, 24, 1044–1048., [CSA], [CROSSREF]
- Miguel, R. (1994). Eutectic mixture of local anesthetics: not just for kids. Regional Anesthesia, 19, 75–76., [PUBMED], [INFOTRIEVE], [CSA]
- Murtha, J. L., & Ando, H. Y. (1994). Synthesis of the cholesteryl ester prodrugs cholesteryl ibuprofen and cholesteryl flufenamate and their formulation into phospholipid microemulsions. Journal of Pharmaceutical Sciences, 83, 1222–1228., [PUBMED], [INFOTRIEVE], [CSA]
- Obata, Y., Sato, H., Li, C. J., Takayama, K., Higashiyama, K., Nagai, T., & Isowa, K. (2000). Effect of synthesized cyclohexanol derivatives using L-menthol as a lead compound on the percutaneous absorption of ketoprofen. International Journal of Pharmaceutics, 198, 191–200., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Passerini, N., Albertini, B., Gonzalez-Rodriguez, M. L., Cavallari, C., & Rodriguez, L. (2002). Preparation and characterisation of ibuprofen-poloxamer 188 granules obtained by melt granulation. European Journal of Pharmaceutical Sciences, 15, 71–78., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Stott, P. W., Williams, A. C., & Barry, B. W. (1998). Transdermal delivery from eutectic systems: enhanced permeation of a model drug. ibuprofen. Journal of Controlled Release, 50, 297–308., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Theis, D. L., Lucisano, L. J., & Halstead, G. W. (1994). Use of stable isotopes for evaluation of drug delivery systems: comparison of ibuprofen release in vivo and in vitro from two biphasic release formulations utilizing different rate-controlling polymers. Pharmaceutical Research, 11, 1069–1076., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wagner, R. F. Jr., Flores, C. A., & Argo, L. F. (1994). A double-blind placebo controlled study of a 5% lidocaine/prilocaine cream (EMLA) for topical anesthesia during thermolysis. Journal of Dermatologic Surgery and Oncology, 20, 148–150., [PUBMED], [INFOTRIEVE], [CSA]
- Yong, C. S., Yang, C. H., Rhee, J. D., Lee, B. J., Kim, D. C., Kim, D. D., Kim, C. K., Choi, J. S., & Choi, H. G. (2004). Enhanced rectal bioavailability of ibuprofen in rats by poloxamer 188 and menthol. International Journal of Pharmaceutics, 269, 169–176., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]